CTRI/2016/11/007500已完成未知
Autologous non cultured dermal cell suspension for correction of facial volume loss
AIIMS New Delhi0 个研究点目标入组 10 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient with visible volume loss on face.
- •2.Controlled underlying systemic disease for at least last 6 months
排除标准
- •1.Pregnancy and lactation
- •2.Keloid or bleeding diathesis
- •3.Active infection at the treatment site.
- •4 .Patient having profound iatrogenic immunosuppression.
- •5.Patient with unrealistic expectations and body dysmorphic disorder.
- •6. Inability to come for follow up upto 6 month.
研究者
相似试验
已完成
不适用
Can adding growth factor from platelets to epidermal cell suspension improve repigmentation in stable vitiligo.A double blinded randomised control studyCTRI/2017/05/008550AIIMS dermatology department20
已完成
1 期
Efficacy assessment of cell therapy with autologous fibroblast in skin agingFace wrinkles.Other specified disorders of skin and subcutaneous tissueIRCT201506271159N17Skin and Stem Cell Research Center, Maryam aley, South kamraneye, Tehran, Iran16
Unknown
不适用
Autologous Keratinocyte Suspension Versus Adipose-Derived Stem Cell-Keratinocyte Suspension for Post-Burn Raw AreaBurn With Full-Thickness Skin LossNCT03686449Assiut University33
已完成
不适用
Autologous cell suspension grafting using ReCell in vitiligo and piebaldism patients: a randomized controlled pilot studyNL-OMON37399Stichting Nederlands Instituut voor Pigmentstoornissen10
已完成
不适用
Autologous cell suspension grafting using ReCell in vitiligo and piebaldism patients: a randomized controlled study on the recipient site preparatiosegmental vitiligo10035023piebaldismNL-OMON42082Academisch Medisch Centrum10